Pharmacokinetics of a Single Dose Faropenem Sodium in Chinese Healthy Volunteers
HU Yu-qin,ZHANG Wei-dong,WANG Ya-chang,HOU Yan-ning
Author information+
Department of Clinical Pharmacology,Bethune International Peace Hospital,Shijiazhuang 050082,China
{{custom_zuoZheDiZhi}}
{{custom_authorNodes}}
{{custom_bio.content}}
{{custom_bio.content}}
{{custom_authorNodes}}
Collapse
History+
Received
Published
2005-09-12
2006-12-05
Issue Date
2006-12-05
Abstract
OBJECTIVE To investigate the pharmacokinetics of Faropenem sodium in Chinese healthy volunteers. METHODS 30 Healthy volunteers (15 male, 15 female) were divided into three groups randomly,and were given a single oral dose (200, 400, 600 mg) of Faropenem sodium tablet.Blood samples were collected from elbow vein at certain sampling times. Faropenem in plasma was determined by HPLC method, and the pharmacokinetic parameters were calculated by DAS software.RESULTS The plasma concentration-time curves of Faropenem are fitted to an one-compartment model after an oral Faropenem sodium tablet in single dose(200, 400, 600 mg). The main pharmacokinetic parameters were as follows:tmax(0.85±0.29),(0.73±0.34) and (0.88±0.29)h;ρmax (2.154±0.65),(4.425±2.403) and (8.126±2.635)mg·L-1;AUC0-t(4.368±1.934),(9.273±7.817) and (18.431±9.167) mg·h·L-1;t1/2(0.642±0.111),(0.769±0.217) and (0.702±0.120) h, respectively.CONCLUSION The plasma concentration-time curves of Faropenem are fitted to an one-compartment model in 30 healthy volunteers after an oral Faropenem sodium tablet in single dose (200, 400, 600 mg), and the ρmax, AUC are increased with dose rising. There is no significant difference in the pharmacokinetic parameters between female and male.
HU Yu-qin;ZHNG Wei-dong;WNG Y-chng;HOU Yn-ning.
Pharmacokinetics of a Single Dose Faropenem Sodium in Chinese Healthy Volunteers [J]. Chinese Pharmaceutical Journal, 2006, 41(23): 1812-1813
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] MURATANI T,YOKOTA E,NAKANE T,et al. In vitro evaluation of the four beta-lactamase inhibitors:BRL42715,clavulanic acid,sulbactam,and tazobactam[J] .J Antimicrob Chemother,1993,32(3):421-429.
[2] SIEGERT R,BERG O,GEHANNO P,et al. Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults[J] .Eur Arch Otorhinolaryngol,2003,260(4):186-194.
[3] AMYES A K B,AMYES S G B. Stability of Faropenem to betalactamases[J] . Am Soc Microbiol,2002:C1-1842-1845.
[4] HU Y Q,ZHANG W D,WANG Y C,et al. Determination of Faropenem sodium in human plasma by HPLC[J] .Chin J Pharm Anal(in press).